Evidence map›Paper›PMID 34422040›Full record

ArticleJournal of toxicology2021

Hepatoprotective Effect of Corm of

Abebe Dukessa Dubiwak, Tesaka Wondimnew Damtew, Mengistu Welde Senbetu, Delenasaw Yewhalaw, Tsegaye Girma Asere, Gebi Nemo, Minale Fekadie Baye

Open access · goldAbstract read
In one paragraph

Article in Journal of toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Nephroprotective Effect ofJournal of toxicology · 2022
    Article
  7. Hepatoprotective Effect ofGlobal advances in integrative medicine and health
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Abebe Dukessa DubiwakDivision of Medical Biochemistry, Department of Biomedical Sciences, Institute of Health Sciences, Jimma University, Jimma, Ethiopia.ORCID https://orcid.org/0000-0002-3260-8382
Tesaka Wondimnew DamtewDivision of Medical Biochemistry, Department of Biomedical Sciences, Institute of Health Sciences, Jimma University, Jimma, Ethiopia.
Mengistu Welde SenbetuDivision of Medical Biochemistry, Department of Biomedical Sciences, Institute of Health Sciences, Jimma University, Jimma, Ethiopia.
Delenasaw YewhalawDepartment of Medical Laboratory Sciences and Pathology, College of Health Sciences, Institute of Health Sciences, Jimma University, Jimma, Ethiopia.
Tsegaye Girma AsereDepartment of Chemistry, College of Natural Sciences, Jimma University, Jimma, Ethiopia.
Gebi NemoDepartment of Pathology, Institute of Health Sciences, Jimma University, Jimma, Ethiopia.
Minale Fekadie BayeDivision of Medical Biochemistry, Department of Biomedical Sciences, Institute of Health Sciences, Jimma University, Jimma, Ethiopia.ORCID https://orcid.org/0000-0002-9338-9953
Jimma University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-induced liver injury (DILI) is one of the cumbersome health-related problems which render approximately 50% of liver failure and patients to receiving liver transplantation every year. Antituberculosis drugs such as isoniazid and rifampicin are potentially rendering hepatotoxicity.

Identifiers

PMID34422040
PMCPMC8378944
OpenAlexW3194245712

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.